AD

Albert Davalos

BA Buck Institute For Research On Aging: 7 patents #14 of 45Top 35%
MF Mayo Foundation: 7 patents #146 of 1,749Top 9%
UB Unity Biotechnology: 7 patents #14 of 35Top 40%
The Johns Hopkins University: 4 patents #1,892 of 4,416Top 45%
📍 San Rafael, CA: #158 of 869 inventorsTop 20%
🗺 California: #82,707 of 386,348 inventorsTop 25%
Overall (All Time): #693,697 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
11963957 Treating cardiovascular disease by selectively eliminating senescent cells Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Jan M.A. van Deursen +2 more 2024-04-23
10328058 Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques Darren J. Baker, Marco Demaria, Bennett G. Childs, Jan M.A. van Deursen, James L. Kirkland +5 more 2019-06-25
10213426 Method of optimizing conditions for selectively removing a plurality of senescent cells from a tissue or a mixed cell population Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Yi Zhu +2 more 2019-02-26
10130628 Treatment of joint pain Nathaniel David, Remi-Martin Laberge, Judith Campisi, Marco Demaria, Alain P. Vasserot +6 more 2018-11-20
9993472 Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +7 more 2018-06-12
9855266 Treatment for osteoarthritis by intra-articular administration of a cis-imidazoline Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +6 more 2018-01-02
9849128 Unit dose of a cis-imidazoline for treating an osteoarthritic joint by removing senescent cells Remi-Martin Laberge, Judith Campisi, Marco Demaria, Nathaniel David, Alain P. Vasserot +6 more 2017-12-26